PYC Therapeutics (ASX:PYC) appoints Doug Huey as CEO to establish Boston office
- Biotech company PYC Therapeutics (PYC) has appointed Douglas Huey as CEO and Board Director
- The current CEO, Rohan Hockings, will step down but will remain a Board Director and Chief Strategy Officer
- Doug has been entrusted to establish a U.S. office based in Boston as the company expands their pipeline
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |